FR2911782A1 - Comment guerir du sida avec mentha pulegium et ginkgo biloba - Google Patents

Comment guerir du sida avec mentha pulegium et ginkgo biloba Download PDF

Info

Publication number
FR2911782A1
FR2911782A1 FR0700736A FR0700736A FR2911782A1 FR 2911782 A1 FR2911782 A1 FR 2911782A1 FR 0700736 A FR0700736 A FR 0700736A FR 0700736 A FR0700736 A FR 0700736A FR 2911782 A1 FR2911782 A1 FR 2911782A1
Authority
FR
France
Prior art keywords
ginkgo biloba
combination
aids
administration
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR0700736A
Other languages
English (en)
Inventor
Jacqueline Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR0700736A priority Critical patent/FR2911782A1/fr
Publication of FR2911782A1 publication Critical patent/FR2911782A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Utilisation de la Mentha Pulégium associée au Ginkgo Biloba pour la préparation d'une composition pour guérir des personnes atteintes du virus du Sida ( VIH ).

Description

DESCRIPTION S En prévision de guérir les gens atteinds dû Sida, je cite
Mentha Pulégium ù 3 gouttes de cette huile déposées sur un cachet neutre buka, associé avec la prise de 3 gélules par jour de Ginkgo Biloba soit 250 mg/gélule. Mentha Pulégium à prendre pendant 21 jours, suivi d'un arrêt de 15 jours puis reprendre à nouveau pendant 21 jours. .i 0 Le Ginkgo Biloba est à prendre pendant tout le temps du traitement soit 57 jours.

Claims (1)

REVENDICATIONS
1.Utilisation de la Mentha Pulégium associée au Ginkgo Biloba pour la préparation d'une composition pour guérir des personnes atteintes du virus du Sida (VIH ).
FR0700736A 2007-01-31 2007-01-31 Comment guerir du sida avec mentha pulegium et ginkgo biloba Withdrawn FR2911782A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0700736A FR2911782A1 (fr) 2007-01-31 2007-01-31 Comment guerir du sida avec mentha pulegium et ginkgo biloba

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0700736A FR2911782A1 (fr) 2007-01-31 2007-01-31 Comment guerir du sida avec mentha pulegium et ginkgo biloba

Publications (1)

Publication Number Publication Date
FR2911782A1 true FR2911782A1 (fr) 2008-08-01

Family

ID=38441661

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0700736A Withdrawn FR2911782A1 (fr) 2007-01-31 2007-01-31 Comment guerir du sida avec mentha pulegium et ginkgo biloba

Country Status (1)

Country Link
FR (1) FR2911782A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0352146A1 (fr) * 1988-07-19 1990-01-24 Abraxas Bio Labs S.A. Régulateur biologique extrait de Gingko Biloba, actif dans diverses pathologies.
FR2754714A1 (fr) * 1996-10-22 1998-04-24 Roc Sa Nouvelles utilisations d'extraits de ginkgo biloba pour la preparation de compositions pharmaceutiques,et methode de traitement cosmetique mettant en oeuvre un extrait de ginkgo biloba
FR2882932A1 (fr) * 2005-03-14 2006-09-15 Jacqueline Martin Utilisation de la menthe pouillot pour traiter le virus du sida

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0352146A1 (fr) * 1988-07-19 1990-01-24 Abraxas Bio Labs S.A. Régulateur biologique extrait de Gingko Biloba, actif dans diverses pathologies.
FR2754714A1 (fr) * 1996-10-22 1998-04-24 Roc Sa Nouvelles utilisations d'extraits de ginkgo biloba pour la preparation de compositions pharmaceutiques,et methode de traitement cosmetique mettant en oeuvre un extrait de ginkgo biloba
FR2882932A1 (fr) * 2005-03-14 2006-09-15 Jacqueline Martin Utilisation de la menthe pouillot pour traiter le virus du sida

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
YOUNG-SU CHANG ET AL: "Korean Medicinal Plants Inhibiting to Human Immunodeficiency Virus Type 1 (HIV-1) Fusion", PHYTOTHERAPY RESEARCH, vol. 17, 2003, pages 426 - 429, XP002449239 *

Similar Documents

Publication Publication Date Title
Duesberg AIDS acquired by drug consumption and other noncontagious risk factors
EP1652520B1 (fr) Formulations utiles pour le traitement de l'impuissance mâle et féminine
EP1658854B1 (fr) Formulations utiles pour le traitement d'impuissance mâle et féminine
DK1341524T3 (da) Farmaceutisk præparat i form af en pasta omfattende en syre-labil aktiv bestanddel
Bell A treatise on gonorrhoea virulenta, and lues venerea
ES2195039T3 (es) Utilizacion de un medicamento y uso de una mezcla de sustancias para la preparacion de un medicamento.
FR2911782A1 (fr) Comment guerir du sida avec mentha pulegium et ginkgo biloba
JP2022118264A5 (fr)
RU2097052C1 (ru) Лекарственный сбор для очищения организма
Kohn Nocturnal orthostatic syncope in pargyline therapy
Mora et al. Self-emasculation and self-castration: immediate surgical management and ultimate psychological adjustment
Shepard Combinations of drugs against Mycobacterium leprae studied in mice
HUP0301408A2 (hu) Szulodexid alkalmazása diabetikus vesebetegség kezelésére szolgáló orális gyógyszerkészítmény előállítására
WO2005030149A3 (fr) Suppression de la replication du vih dans la prevention et le traitement du vih
AR042152A1 (es) Uso de los compuestos 2,5 dihidroxibencesulfonicos para la fabricacion de un medicamento para pacientes diabeticos
Garfinkel et al. L-Dopa and schizophrenia
DK1143976T3 (da) Beta-D-2', 3'-didehydro-2', 3'-dideoxy-5-fluorcytidin til anvendelse i behandlingen af HIV-infektioner
Enarson Strategies for the fight against tuberculosis
KR910007528A (ko) 벤조디아제핀 및 페닐피릴케톤 유도체의 용도
US20220226414A1 (en) COVID-19 Treatment
Kshirsagar et al. Utility of Bowel Nosodes in the Treatment of Chronic Diseases-A Case Series
MA49754B1 (fr) Méthodes de traitement de symptômes de gastroparésie au moyen de velusetrag
CN2181889Y (zh) 药物保健生活用纸
Cosentino et al. Priapism secondary to tamsulosin: a case report
DK1448184T3 (da) Anvendelse af propionyl-L-carnitin eller et af dets farmakologisk acceptable salte til fremstilling af en medicin til behandling af Peyronies sygdom

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20100930